Olivia has developed expertise across a range of therapeutics areas over the course of 7+ years of experience in life sciences research and consulting, but she has a specific interest in rare diseases, immunology, and ophthalmology. In particular, she has a passion for supporting clients with highly innovative technology platforms in the development and commercialization of their therapies for patients with significant unmet need. During her time at ClearView, Olivia has assisted a wide array of clients, ranging from leading biopharmaceutical companies to early-stage biotechs, in addressing their highest-priority strategic issues. Through this diversity of experience, Olivia has a demonstrated track record of ensuring commercial, clinical, and scientific factors are effectively considered to address her clients’ strategic questions.
While her historical experience spans a broad range of project types, Olivia focuses on commercialization strategy, including new product planning, portfolio prioritization, M&A and due diligence support, and strategic launch planning. Olivia received her B.A. in Economics and a Secondary Field in Chemistry from Harvard University.
Debbi Amanti Belanger
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Dean Griffiths
Kim Goh
Slater Hurst
Ketan Kapadia
Philip Kenner
Jessica Lee
Stuart MacGregor
Charles Mathews
David McClain
Kai-Ming Pu
Richard Mynahan
Kevin Richard
Derek Riesenberg
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Michael Agne
Jonathan Betts
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Dave Konciak
Alexander Lehrman
Matthew Pfister
Olivia Piccione
Sarah Stapleton
Brian Quinn
Kelsey Yardumian
Jake Arakal
Kali Barnes
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Joanna Lee
Angela Liu
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Shachi Patel
Cem Salfati
Sam Smith
Jim Duffy
Lainey Miller
Melanie Robinson